Article Information
History
- May 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jose I. de las Heras1,
- Vanessa Todorow2,
- Lejla Krečinić-Balić2,
- Stefan Hintze2,
- Rafal Czapiewski1,
- Shaun Webb3,
- Benedikt Schoser2,
- Peter Meinke2,* and
- Eric C. Schirmer1,*
- 1Institute of Cell Biology, University of Edinburgh, Edinburgh, UK
- 2Friedrich-Baur-Institute, Department of Neurology, LMU Clinic, Ludwig-Maximillians-University, Munich, Germany
- 3Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK
- ↵*Co-corresponding authors: Eric C. Schirmer Institute of Cell Biology; University of Edinburgh, Kings Buildings; Michael Swann Building, Room 5.22; Max Born Crescent; Edinburgh, EH9 3BF, UK; Phone: +441316507075; E-mail: e.schirmer{at}ed.ac.uk, Peter Meinke, Friedrich-Baur-Institute, Department of Neurology, LMU Clinics, Ludwig-Maximillians-University, Ziemssenstrasse 1, 80336 Munich, Germany; Phone +4989218078279; E-mail: Peter.Meinke{at}med.uni-muenchen.de
Posted May 20, 2022.
Metabolic, Fibrotic, and Splicing Pathways Are All Altered in Emery-Dreifuss Muscular Dystrophy Spectrum Patients to Differing Degrees
